Since 2013, Delbert Pharma has been preserving the market availability of drugs considered critical to our healthcare system and repositioning some for new indications, notably in rare diseases. Our commitment, as defenders of the pharmaceutical heritage, is to maintain access to essential medications to ensure the continuity of treatments for all. To support their European development, Laboratoires DELBERT become DELBERT Pharma in March 2024. This page is not intended to report adverse events that may be related to the medications marketed by Delbert Pharma. For this, please contact your healthcare professional. Delbert Pharma constantly monitors the safety of its drugs and encourages you to report any side effects directly at +33 (0) 1 46 99 68 20 or pharmacovigilance@delbert.fr. #RevivingCriticalMedicines
| Website | https://delbertpharma.com |
| Employees | 26 (19 on RocketReach) |
| Address | 49, Rue Rouelle, Paris, Île-de-France 75015, FR |
| Industry | Pharmaceutical Manufacturing |
| Keywords | Pharmacovigilance, Pharmaceutical Manufacturing, Drug Development, Rare Disease Therapeutics, Drug Repositioning, Generic Drugs, Pharmaceutical Supply Chain, Healthcare Solutions, Clinical Trials, Fda Regulations, Pharmaceutical Research, Drug Commercialization, Drug Distribution, Pharmaceutical Marketing, Medical Affairs, Regulatory Affairs |
| Competitors | Boehringer Ingelheim, Teva Pharmaceuticals, Sandoz, SUN PHARMA, Dr. Reddy's Laboratories, Fresenius Kabi, Cipla, Apotex Inc., Zydus Cadila Healthcare Limited, Mylan Belgium +41 more (view full list) |
Looking for a particular Delbert Pharma employee's phone or email?
Delbert Pharma Questions
Guillaume Bellon is the CFO of Delbert Pharma.
19 people are employed at Delbert Pharma.
Delbert Pharma is based in Paris, Île-de-France.
Top Delbert Pharma Employees
-
Nancy Harvel
Directeur Qualité et Affaires Pharmaceutiques at Delbert Pharma
Rieux, Hauts-de-France, FR
